Welcome to the 5th Commercializing Clinically Validated Digital Therapeutics Summit, The Conference With Practical Answers
The 5th Commercializing Clinically Validated Digital Therapeutics Summit returns in 2022 to unite all players in the DTx ecosystem - including DTx companies, pharma, regulators, payors, clinicians, and patients - to offer a rounded overview of the landscape’s challenges and provide a forum to collaboratively form solutions.
What’s New in 2022?
This is your only opportunity to learn from DTx leaders on key topics such as:
- Assess a fit-for-purpose clinical trial development for DTx, to effectively create validating evidence with The Henry M. Jackson Foundation
- Evaluate how the ecosystem will evolve to maximize commercial expansion with the Digital Therapeutics Alliance
- Dissect how DTx can add value to patients’ usability, safety, clinical outcomes and adherence with Ciba Health, and TrainPain
- Incorporate gamification into DTx to increase engagement from patients with TrainPain and Tilak Healthcare
- Develop a patient centric approach to designing DTx by understanding their perspective with Roche
Unique to CCVDTx Summit
- Understand clinical trial development for digital therapeutics with The Henry M. Jackson Foundation and discover emerging trends in game design for digital health with TrainPain in over 4 hours of content shared during the Pre-Conference Workshop Day
- Immerse yourself in the many interactive sessions and discuss your peers’ approaches to involving the patient a patient centric approach, engaging different stakeholders, creating fit-for-purpose clinical trial development for DTx, to effectively create validating evidence and more
With increased momentum for digital therapeutics with the increased commercial coverage and interest from the FDA, join us to further your understanding of DTx scalability, to enable the building of sustainable & viable business models.
Networking: network one-to-one with industry leaders prioritizing the challenges of reimbursement & pricing, market access, ROI, establishing regulatory frameworks, utilizing RWE, patient usability & product development to understand their work to accelerate successful commercialization of your DTx.
Tangible Takeaways: hear first-hand from leading experts on mechanisms of action and success stories and lessons learned to enable you to benchmark your decisions against the actions of others and conquer challenges before you face them.
Discover: discover and discuss novels approaches and methods of market access, patient adoption and commercialization models by interacting with a variety of leaders in the field, igniting & brainstorming new ideas for your DTx.